
|Articles|May 21, 2019
Navitas Life Sciences Announces Acquisition of KAI CRO
Advertisement
Navitas Life Sciences announced the acquisition of US based niche full service CRO and health research company, KAI Research Inc. KAI Research brings offerings in three key areas to the table – Clinical Trial Management, Clinical Research Consultation, and Data Management & Standardization.
For more details on the acquisition, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
2
Setting the Limits of Autonomy with Autonomous Agents for Clinical Research
3
Adaptive Trial Design as a Pathway to Faster Development
4
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
5